GURE News 2.11 Gulf Resources (GURE)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gulf Resources (GURE) 2.11 $GURE

Why Gulf Resources (GURE) Hit a One-Year High Today
at The Street - Tue Mar 18, 12:21PM CDT
Gulf Resources (GURE) hit a one-year high of $3.20 as of 1:10 p.m. on Tuesday after the bromine and crude salt supplier reported its fourth-quarter and full-year earnings. For the fourth quarter ended Dec. 31, 2013, the company reported a 195%...

Gulf Resources Reports Fourth Quarter and Fiscal Year 2013 Financial Results
GlobeNewswire - Mon Mar 17, 5:00PM CDT
Gulf Resources, Inc. (Nasdaq:GURE) ("Gulf Resources" or the "Company", a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2013.

Gulf Resources Schedules Fourth Quarter & Full Year 2013 Earnings Call
GlobeNewswire - Fri Mar 14, 7:00AM CDT
Gulf Resources, Inc. (Nasdaq:GURE) ("Gulf Resources" or the "Company", a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced that company management will hold its quarterly conference call to discuss fourth quarter and full year 2013 results on Tuesday, March 18, 2014, at 8:00 a.m. Eastern Time.

Gulf Resources Announces Final Approval of Settlement of Class-Action Lawsuit
GlobeNewswire - Mon Feb 10, 8:00AM CST
Gulf Resources, Inc. (Nasdaq:GURE) ("Gulf Resources" or the "Company", a leading manufacturer of bromine, crude salt and specialty chemical products in China, today reported that the United States District Court for the Central District of California Western Division entered an Order and Final Judgment approving the settlement and dismissing the class-action lawsuit against Gulf Resources and a number of its current directors and officers.

Gulf Resources Reports Its 2013 10-K Filing Schedule
GlobeNewswire - Tue Jan 28, 7:30AM CST
Gulf Resources, Inc. (Nasdaq:GURE) ("Gulf Resources" or the "Company", a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced it will file its 2013 10-K report on schedule in compliance with SEC rules.

10-Q: UNITED JET CENTER INC
Edgar Online - Tue Jan 14, 2:41PM CST
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

5 Stocks Under $10 Set to Soar
at The Street - Thu Dec 05, 1:12PM CST
These under-$10 stocks look ready to trade higher from current levels.

5 Stocks Under $10 Making Big Moves
at The Street - Fri Nov 15, 7:15AM CST
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Gulf Resources to Host Third Quarter 2013 Earnings Webcast Live on Monday, November 11, 2013
ACCESSWIRE - Mon Nov 11, 1:20AM CST
SHANDONG, CHINA - (ACCESSWIRE - November 8, 2013) - Gulf Resources, Inc. (GURE) will host a live webcast to discuss the results of the third quarter 2013, to be held Monday, November 11, 2013 at 8:00 a.m. Eastern Time.

Gulf Resources Reports Third Quarter 2013 Financial Results
GlobeNewswire - Fri Nov 08, 3:30PM CST
Gulf Resources, Inc. (Nasdaq:GURE) ("Gulf Resources" or the "Company", a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced its financial results for the third quarter ended September 30, 2013.

Watch for a Big Short Squeeze in Cleantech Solutions
at The Street - Tue Oct 22, 4:30AM CDT


Portfolio Expansions, Executive Appointments, Compensation Agreements, and Conference Call Schedules - Research Report on LyondellBasell, Westlake Chemical, Gulf Resources, IFF, and NewMarket
PR Newswire - Mon Oct 21, 7:00AM CDT
Today, Analysts' Corner announced new research reports highlighting LyondellBasell Industries NV (NYSE: LYB), Westlake Chemical Corp. (NYSE: WLK), Gulf Resources, Inc. (NASDAQ: GURE), International Flavors & Fragrances Inc. (NYSE: IFF), and NewMarket Corp. (NYSE: NEU). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Bottini & Bottini, Inc. and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Gulf Resources, Inc. -- GURE
GlobeNewswire - Thu Aug 15, 7:00AM CDT
Bottini & Bottini, Inc. and The Rosen Law Firm, P.A. announce that the United States District Court Central District of California Western Division has approved the following announcement of a proposed class action settlement that would benefit purchasers of common stock of Gulf Resources, Inc. (Nasdaq:GURE):

Gulf Resources Reports Second Quarter 2013 Financial Results
GlobeNewswire - Fri Aug 09, 4:00PM CDT
Gulf Resources, Inc. (Nasdaq:GURE) ("Gulf Resources" or the "Company", a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced its financial results for the second quarter ended June 30, 2013.

Gulf Resources Reports First Quarter 2013 Financial Results
GlobeNewswire - Thu May 09, 4:00PM CDT
Gulf Resources, Inc. (Nasdaq:GURE) ("Gulf Resources" or the "Company", a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced its financial results for the first quarter ended March 31, 2013.

Gulf Resources Announces $2 Million Share Repurchase Program
GlobeNewswire - Thu Apr 18, 7:30AM CDT
Gulf Resources, Inc. (Nasdaq:GURE) ("Gulf Resources" or the "Company", a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced that the Company's Board of Directors has approved a new share repurchase program under which the Company is authorized, but not obligated, to purchase up to $2 million of its issued and outstanding shares of common stock from time to time over the next 12 months. The timing and amount of any repurchase will depend on market conditions, the trading price, and other factors. Such repurchases will be subject to, and executed in compliance with, applicable laws and regulations. The share repurchase program may be suspended, modified or discontinued at any time. The share repurchase program will be funded with the Company's available working capital. Currently the Company is under its normal operation and does not possess any material non-public information.

Gulf Resources Inc anticipates lower revenue and net income in fiscal 2013
M2 - Tue Jan 22, 8:22AM CST
Chinese chemical products company Gulf Resources Inc (NasdaqGS :GURE) said on Monday that it expects its total revenue and net income of approximately USD122.8m and USD18.7m, respectively, in fiscal year 2013.

Gulf Resources Provides 2013 Fiscal Year Financial Guidance
GlobeNewswire - Mon Jan 21, 7:30AM CST
Gulf Resources, Inc. (Nasdaq:GURE) ("Gulf Resources" or the "Company", a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced financial guidance for fiscal year 2013.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading